# Alto Ingredients, Inc. (ALTO)

> Source: Nexqual · https://nexqual.com/ALTO · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Alto Ingredients, Inc. (ALTO), nexqual.com/ALTO" · informational, not investment advice.

**Price:** USD 3.66 (-1.08% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 3.7 · day 3.6–3.69 · 52w 0.99–6.11 · market cap $284M · NCM

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $943M, net income $52.0M (5.5% margin), free cash flow $49.9M (SEC filings).
- Valuation: P/E 5.5x (avg 16.3x at the last 1 fiscal year-ends), EV/EBITDA 5.3x, net debt $36.5M.
- Analysts: Buy (mean 2.00 on a 1–5 scale) (3 analysts), mean target USD 8.33 (range 7–10).
- Total return with dividends: 1Y +221.1% vs S&P 500 +18.1%; 5Y -34.4% vs S&P 500 +85.1%.
- Next earnings: 2026-11-04, EPS estimate USD 0.11, revenue estimate $251M.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $1.21B | $1.34B | $1.22B | $965M | $918M | $943M |
| Gross profit | $67.8M | -$27.6M | $15.7M | $9.7M | $34.9M | — |
| Operating income | $40.1M | -$61.4M | -$23.8M | -$51.7M | $7.4M | $35.6M |
| Net income | $46.1M | -$41.6M | -$28.0M | -$59.0M | $13.3M | $52.0M |
| EPS (diluted) | $0.61 | -$0.60 | -$0.40 | -$0.82 | $0.16 | — |
| Free cash flow | $10.4M | -$31.7M | -$7.5M | -$14.6M | $8.6M | $49.9M |
| Gross margin | 5.6% | -2.1% | 1.3% | 1.0% | 3.8% | — |
| Operating margin | 3.3% | -4.6% | -2.0% | -5.4% | 0.8% | 3.8% |
| Net margin | 3.8% | -3.1% | -2.3% | -6.1% | 1.5% | 5.5% |
| Revenue growth | +34.7% | +10.6% | -8.4% | -21.1% | -4.9% | — |
| Cash + short-term investments | $50.6M | $36.5M | $30.0M | $35.5M | $23.4M | — |
| Total debt | $50.4M | $68.4M | $82.1M | $92.9M | $79.6M | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/E 5.5x · P/S 0.3x · EV/EBITDA 5.3x · EV/Sales 0.3x · P/FCF 5.7x · P/B 1.1x · FCF yield 17.59% · Earnings yield 18.31% · Net debt $36.5M · EV $320M
P/E at fiscal year-ends: Dec 2025 16.3x.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 3 analysts; mean target USD 8.33 (low 7, high 10).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-30 | StoneX | Initiated | Buy | $7 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | +221.1% | -34.4% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +222.3% | -8.1% |
| Volatility (annualized) | 86.4% | 83.0% |
| Max drawdown | -39.4% (May 2026→Sep 2026) | -88.7% (Apr 2022→Apr 2025) |

## Peers (Specialty Chemicals)
CLMT (Calumet, Inc) USD 58.24 -0.60% · BCPC (Balchem Corporation) USD 170.53 +0.48% · SXT (Sensient Technologies Corporati) USD 133.42 +0.66% · AXTA (Axalta Coating Systems Ltd.) USD 33.73 +0.60% · EMN (Eastman Chemical Company) USD 63.87 +1.38% · WLK (Westlake Corporation) USD 63.61 +2.83%

## More
Full page: https://nexqual.com/ALTO · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt